Evidence that the human death receptor 4 is regulated by activator protein 1 (Q28206926)

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

The TRAIL to selective tumor death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Apoptotic pathways: paper wraps stone blunts scissors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

The regulation of AP-1 activity by mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

The potential of TRAIL for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Nuclear retinoic acid receptors: cloning, analysis, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

A sensitive method for the determination of protein-DNA binding specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

AP-1 in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

AP-1: one switch for many signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

On the TRAIL to a new cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

7 January 2021

Avoiding premature apoptosis of normal epidermal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

7 January 2021

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

7 January 2021

Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205430

7 January 2021